Sugarloaf Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-4,750
| Closed | -$4.21K | – | 796 |
|
2022
Q4 | $4.21K | Buy |
4,750
+2,050
| +76% | +$1.82K | ﹤0.01% | 600 |
|
2022
Q3 | $5K | Sell |
2,700
-800
| -23% | -$1.48K | ﹤0.01% | 628 |
|
2022
Q2 | $7K | Buy |
3,500
+2,500
| +250% | +$5K | ﹤0.01% | 563 |
|
2022
Q1 | $2K | Buy |
+1,000
| New | +$2K | ﹤0.01% | 655 |
|
2021
Q1 | – | Sell |
-2,000
| Closed | -$14K | – | 792 |
|
2020
Q4 | $14K | Buy |
2,000
+1,675
| +515% | +$11.7K | ﹤0.01% | 448 |
|
2020
Q3 | $4K | Buy |
+325
| New | +$4K | ﹤0.01% | 557 |
|